Pouneh Bligaard
Editas Medicine may be the most under-priced player in gene editing, with a major upcoming data catalyst

Editas Medicine is one of a handful of listed gene editing companies pioneering the use of CRISPR - clustered, regularly interspaced, short palindromic repeats - to create molecules that “efficiently and specifically” edit DNA. Most people have heard of CRISPR and the ground-breaking technology capable of transforming healthcare....

Continue reading →
Editas Medicine may be the most under-priced player in gene editing, with a major upcoming data catalyst
Pouneh Bligaard
September 16, 2021
Frontier IP: Early stage technology exposure
Pouneh Bligaard
September 9, 2021
Kromek: Well placed in the aftermath of Covid
Pouneh Bligaard
September 3, 2021
Litigation Capital Management: Potential under the radar…
Pouneh Bligaard
August 25, 2021
Regeneron Pharmaceuticals - Priced at Deep Value, Poised For Explosive Growth
Pouneh Bligaard
August 18, 2021
Thesis Portfolio thesis descriptions: Scrooge McBuck
Pouneh Bligaard
August 5, 2021
Pynk is a registered trademark and copyright of Crowdsense Ltd. Crowdsense Ltd is a company registered in England and Wales (No. 11339494) with the registered office at 20-22 Wenlock Road, London, England, N1 7GU.

Crowdsense Ltd is an unregulated firm and the information contained herein does not constitute investment advice or investment research and should not be relied upon to make any investment decisions.

Crowdsense Ltd is partnered with Pynk One Ltd, trading as Thesis Portfolio. Pynk One Ltd (FCA reference no. 942958) is an appointed representative of WealthKernel Limited (FCA reg no. 723719), which is authorised and regulated by the Financial Conduct Authority.

Investing involves risk to your capital. Past performance is not an indication of future results. The value of your investments can go down as well as up, and you may get back less than you originally invested. References to specific assets or securities are included for illustrative purposes and should not be understood as an endorsement or a recommendation to engage in investment activities.

Please invest aware.

Warning - Unregulated to Regulated

You are passing from the Pynk to the Thesis Portfolio area of this site.

Pynk is a brand name of Crowdsense Ltd. Crowdsense Ltd is not authorised and its activities are not regulated by the FCA. As such any activity you undertake with Crowdsense will not be protected under any investor compensation scheme e.g. the FSCS.

Thesis Portfolio is a trading name of Pynk One Ltd (FRN 12940786). Pynk One Ltd is an Appointed Representative of Wealthkernel Ltd (FRN 723719) who are authorised and regulated by the Financial Services Authority. As such your deposits and investments may be protected by an investor compensation scheme i.e the FSCS if Pynk One Ltd is unable to meet its obligations.